Skip to content
Open in App
Addex Therapeutics logo

Addex Therapeutics

web2

Addex Therapeutics is a Swiss clinical stage biopharmaceutical company developing small molecul...

Symbol ยท ADXN
Company profile

About

Addex Therapeutics is a Swiss clinical stage biopharmaceutical company developing small molecule medicines that modify neurological signaling pathways to investigate treatments for central nervous system disorders. Its research focuses on allosteric modulators, compounds that influence receptor activity by binding at sites distinct from the receptor's principal signaling site. Development programs include candidates targeting GABAB receptors for chronic cough and substance use disorders, alongside other neurological applications. The company also has interests in Neurosterix, a separately developed drug discovery business. Addex conducts pharmaceutical research and clinical development rather than operating as a commercial supplier of approved medicines.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNasdaqPrimary symbol: ADXN
ExchangeSwitzerlandPrimary symbol: ADXN
Expert coverage

Addex Therapeutics profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment